Here, we showed that specific class I and class II HDAC genes are significantly overexpressed in AML patients compared to healthy controls and that combinatory treatment of AML cell lines with the class IIA HDAC inhibitor TMP269 and venetoclax leads to increased induction of cell apoptosis. Here, HDAC9 is linked to acute myeloid leukemia.